Your session is about to expire
← Back to Search
Hydrocortisone + Prolonged Exposure Therapy for PTSD
Study Summary
This trial is testing whether adding hydrocortisone to Prolonged Exposure therapy, an effective treatment for PTSD, will make the therapy more effective.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had a moderate or severe brain injury.I have a health issue that needs urgent care, not related to PTSD.My mental health medication has been the same for less than a month.I have diabetes or another illness that makes it unsafe for me to take steroids.I have chronic PTSD from a deployment-related event with a severity score of at least 50.I have been on the same mental health medication for at least a month or am not taking any.I am willing to stop other PTSD therapies for 16 weeks.
- Group 1: Prolonged Exposure therapy with placebo
- Group 2: Prolonged Exposure therapy with Hydrocortisone
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 60 Other Conditions - This treatment demonstrated efficacy for 60 other conditions.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the upper capacity of individuals who can partake in this scientific exploration?
"This clinical trial has ceased patient recruitment, as the last update was posted on February 4th 2013. However, if you are seeking medical studies related to stress and traumatic disorders there 416 trials that are still recruiting participants and 60 studies involving Prolonged Exposure therapy with Hydrocortisone which have open slots for volunteers."
What have prior studies revealed regarding the effectiveness of Prolonged Exposure therapy in conjunction with Hydrocortisone?
"Currently, there are 60 trials that examine the efficacy of Prolonged Exposure therapy with Hydrocortisone in operation. 20 out of these clinical studies have reached Phase 3 status. These medical experiments mainly take place around New york City; however, this treatment is being studied by 3054 facilities across the state."
Is this research accessible to individuals below the age of fifty-five?
"The study requires volunteers aged between 18 and 89, however there are 76 trials for minors and 352 for seniors."
In what contexts is Prolonged Exposure therapy with Hydrocortisone utilized?
"Prolonged Exposure therapy with Hydrocortisone has been shown to have a positive effect in managing ulcerative colitis as well as malignant neoplasms, varicella-zoster virus acute retinal necrosis, and crohn disease."
Is there still opportunity for patients to participate in this clinical research?
"Per the data available on clinicaltrials.gov, this trial is no longer accepting applications and has not been recently updated since February 4th 2013 when it was first posted in 2010. However, there are still a plethora of other studies that require patient participation at the present moment."
Am I qualified to participate in this medical trial?
"This experiment is seeking 50 volunteers who suffer from stress disorders and/or traumatic events. Prospective participants should be aged between 18 and 89 to qualify for enrollment."
Share this study with friends
Copy Link
Messenger